Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction
about
Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinasesDual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinomaEpstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling moduleThe EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfoldIdentification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome.Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19The LMP2A ITAM is essential for providing B cells with development and survival signals in vivoEBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.Modulation of the cell growth regulator mTOR by Epstein-Barr virus-encoded LMP2A.Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latencyLatent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.PY motifs of Epstein-Barr virus LMP2A regulate protein stability and phosphorylation of LMP2A-associated proteins.C-terminal domain of the Epstein-Barr virus LMP2A membrane protein contains a clustering signalBtk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy.Itchy, a Nedd4 ubiquitin ligase, downregulates latent membrane protein 2A activity in B-cell signaling.Length of Epstein-Barr virus termini as a determinant of epithelial cell clonal emergenceEpstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosisCholesterol is critical for Epstein-Barr virus latent membrane protein 2A trafficking and protein stabilityEpstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway.Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.Latent membrane protein 2B regulates susceptibility to induction of lytic Epstein-Barr virus infectionAn auto-regulatory loop for EBV LMP2A involves activation of Notch.Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase LynLatent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway.Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling.Induction of therapeutic antibodies by vaccination against external loops of tumor-associated viral latent membrane protein.LMP2A does not require palmitoylation to localize to buoyant complexes or for function.Role of the immunoreceptor tyrosine-based activation motif of latent membrane protein 2A (LMP2A) in Epstein-Barr virus LMP2A-induced cell transformation.Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation.Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2AThe YXXL sequences of a transmembrane protein of bovine leukemia virus are required for viral entry and incorporation of viral envelope protein into virions.Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus
P2860
Q24515076-C0AD8194-24DB-4D67-A816-C0B1C6A2B46AQ24610485-105EEACF-30FD-4C4C-A41F-C7C4511BC308Q24675538-A343E65A-D20B-4BE4-B872-CE6688403C3BQ24685733-3C8310B7-A70B-4F53-9D88-E4E66ADD9824Q30175290-F4CFF470-0D37-4125-AC88-CCF51AF2FAFFQ30425512-DBC54811-CE7E-4C8C-8DFE-B66F146FD3C8Q33604616-83B989BF-E1CA-40EB-B24F-B5B8275F0EFDQ33739672-8DC98BE4-65A3-435C-A4D3-FC22C06CF865Q33754907-EA03F6A8-6010-4E41-9EB5-BAEEA918CF6CQ33784647-6578AD90-BE74-4044-AE8E-8846565A947EQ33787396-487A65E8-41C8-4D94-AFE5-C62A7D67E4B3Q33813796-3841AB65-65DC-4993-A44F-DF66684051DBQ33842129-1B4BB1C1-B4B2-4932-8EA4-03B105F45DA7Q33849076-3FCB3A8D-CB66-412E-9A1F-175E57FBF47CQ33888592-2D5724D5-2B0C-4EC0-AE37-0F4618F0916EQ33889168-DCC9B3DF-0236-4749-A40C-81FCB1F09E94Q33918592-304CA5C7-C3F5-49AD-A377-667512004111Q34310840-D6048C79-2933-4410-BCC3-C1709034F552Q34975783-39007A61-B3D1-442F-98C7-CCC55FAAB7B9Q35155351-59B2D91F-4DF8-4429-85E2-9F5F563A503DQ35291650-930319BA-6FBF-4643-8DE9-4E080BB9E117Q35634286-1172644E-D5F5-412E-9806-E95E718FF000Q35642734-EA533DF5-E9AA-4A0E-B750-659D262923EDQ35793738-B76F0C3A-D25A-40B0-B33E-EBD049DAA1BFQ35948025-EDDE9A33-6A5A-4350-99FF-DEC4E0EE7D23Q36040966-2F9ED200-21ED-47E8-BBBC-37C3B3D01C6EQ36483287-B0E853FF-0B6F-41E2-B4A8-8929C06B041FQ36528115-DA046F6A-6B5B-4DA1-AE75-F48EBD8680D9Q36845865-F6E11523-70AD-44DC-A6A0-5718ACCC7088Q36961820-08E834AD-04AB-4249-B872-DFCE497056CFQ37394390-6B0AD25F-FDFB-42E2-8FF0-E89FC847FE83Q37400412-69CFCCCD-5765-47F4-AA1B-24C4835B679AQ37410691-8F760265-2B0B-41A2-8815-3D0AC605A365Q37567931-3DB0E491-6769-4A51-841F-C76B2D1025E7Q38860330-7F947823-9396-4E05-8BAE-833C6E99E440Q39148562-01B4873D-8CAB-4EC7-9DCB-26195644CBEBQ39304933-3AF7F6B3-A51F-4A66-B383-FCC1D42700D2Q39549376-EFEBB9F9-B337-4DA1-9E07-4F991AD50B0CQ39585482-8DDBFEE1-53F2-41E9-9F94-60A73CE9082BQ39595507-4DDC3304-D802-4592-8E11-4B12767274A1
P2860
Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Identification of latent membr ...... noglobulin signal transduction
@ast
Identification of latent membr ...... noglobulin signal transduction
@en
type
label
Identification of latent membr ...... noglobulin signal transduction
@ast
Identification of latent membr ...... noglobulin signal transduction
@en
prefLabel
Identification of latent membr ...... noglobulin signal transduction
@ast
Identification of latent membr ...... noglobulin signal transduction
@en
P2093
P2860
P1433
P1476
Identification of latent membr ...... noglobulin signal transduction
@en
P2093
F A Grässer
R Longnecker
S Fruehling
P2860
P304
P407
P577
1996-09-01T00:00:00Z